Skip to main content
. 2019 Jul 11;44(1):67–77. doi: 10.4093/dmj.2018.0274

Table 3. Adverse events summary.

Variable Pioglitazone (n=69) Glimepiride (n=66) P value
Adverse eventa 64 (92.8) 58 (87.9) 0.504
 Hypoglycemia 3 (4.4) 16 (24.2) 0.002
 Upper respiratory infection 10 (14.5) 6 (9.1) 0.481
 Dizziness 5 (7.3) 5 (7.6) 1.000
 Headache 3 (4.4) 2 (3.0) 1.000
 Weight gain 4 (5.8) 0 0.120
 Dyspepsia 0 4 (6.1) 0.055
 Acute diarrhea 2 (2.9) 1 (1.5) 1.000
 Itching 3 (4.4) 0 0.245
 Edema 3 (4.4) 0 0.245
 Abdominal pain 2 (2.9) 0 0.497
 Ache 2 (2.9) 0 0.497
 Myalgia 2 (2.9) 0 0.497
 Palpitation 0 2 (3.0) 0.237
Serious adverse event 3 (4.4) 0 0.245
 Fractureb 2 (2.9) 0 1.000
 Acute pyelonephritis 1 (1.5) 0 1.000
Adverse drug reaction 8 (11.6) 23 (34.9) 0.003
 Hypoglycemia 1 (1.5) 14 (21.2) 0.001
 Dizziness 1 (1.5) 3 (4.6) 0.358
 Weight gain 2 (2.9) 0 0.497
 Edema 2 (2.9) 0 0.497

Values are presented as number (%).

aOccurring in frequencies of ≥2% in either treatment group, bFractures of cuneiform bone of foot and intertrochanteric section of femur after falling.